DOJ blasts industry attempt to delay Medicare drug price negotiations – By Joseph Choi (The Hill) / Aug 14, 2023
The Department of Justice (DOJ) lambasted the Chamber of Commerce’s request for an injunction to block the Medicare drug price negotiation program, arguing in court filings that the organization had no standing to file the lawsuit and that pausing the program would harm the public.
The rebuttal comes weeks before the federal government is expected to name the first 10 drugs chosen for price negotiation.
The Chamber filed a motion in July for a preliminary injunction against the Medicare Drug Price Negotiation Program, claiming it would inflict “irreparable harm” on U.S. businesses and patients.
The DOJ pushed back, pointing out that companies won’t feel the impact of the negotiated prices until at least 2026 and saying this case could be “fully litigated” by that point.
